Pharmaco - Press Releases

Date	Title	Company
04-Jan-2023	SYNLAB AG: Proceedings of the Portuguese Competition Authority against entities of SYNLAB	SYNLAB AG
04-Jan-2023	Hummingbird Bioscience and Synaffix Enter License Agreement to Develop a Next Generation Antibody Drug Conjugate (ADC) Program	Hummingbird Bioscience
04-Jan-2023	Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers	Biognosys and Bruker
04-Jan-2023	Janssen Submits Marketing Authorisation Application to the European Medicines Agency Seeking Approval of Talquetamab for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma	Janssen Pharmaceutical Companies of Johnson & Johnson
04-Jan-2023	Calibre Scientific Acquires TechniVal Group, a Comprehensive Provider of Laboratory Equipment Services in the United Kingdom	Calibre Scientific
04-Jan-2023	Actimed Therapeutics successfully closes second tranche of £10m seed financing to progress pipeline for treatment of cancer cachexia and other muscle wasting disorders	Actimed Therapeutics
04-Jan-2023	Availability of the Q4 Memorandum for modelling purposes	Sanofi
04-Jan-2023	WuXi STA Launches First Continuous Manufacturing Line for Oral Solids	WuXi STA
04-Jan-2023	Straumann Group appoints interim Chief Financial Officer	Straumann Holding AG
03-Jan-2023	Tiziana Life Sciences Announces Additional Clinical Improvements in the Second Patient with Non-Active Secondary Progressive Multiple Sclerosis (SPMS) After Eleven Months of Dosing with Intranasal Foralumab	Tiziana Life Sciences
03-Jan-2023	iTeos to Present at the 41st Annual J.P. Morgan Healthcare Conference	iTeos Therapeutics
03-Jan-2023	PharmaSGP Holding SE resolves on buyback program for own shares of up to 1.5 million Euro	PharmaSGP Holding SE
03-Jan-2023	Astex Co-founder and CEO Harren Jhoti Awarded OBE in the King’s New Year Honours	Astex Pharmaceuticals
03-Jan-2023	Drägerwerk AG & Co. KGaA: Dräger redeems last participation certificates – streamlining of capital structure completed	Drägerwerk AG & Co. KGaA
03-Jan-2023	Newron announces striking six-month interim results from its exploratory clinical trial evaluating evenamide as add-on therapy for patients with treatment-resistant schizophrenia	Newron Pharmaceuticals S.p.A.
27-Dec-2022	Marinomed Biotech AG: Marinomed Biotech receives US Patent approval for the Marinosolv® technology and invests in a series of new patents	Marinomed Biotech AG
27-Dec-2022	Relief Therapeutics Files Amendment No. 2 to its Registration Statement on Form F-1 with the U.S. Securities and Exchange Commission	Relief Therapeutics Holding SA
27-Dec-2022	Acer Therapeutics and Relief Therapeutics Announce U.S. FDA Approval of OLPRUVA™ for Patients with Urea Cycle Disorders	Relief Therapeutics Holding SA
23-Dec-2022	Pareto Securities AS publishes buy recommendation for Epigenomics AG share	Epigenomics AG
22-Dec-2022	10-year Moderna deal underlines UK potential for global life science leadership	Moderna